2016 Drug Discovery Conference | Stanford University
Hosted by the Stanford Cardiovascular Institute | March 29, 2016
Chris Austin, MD
Director
National Center for Advancing Translational Sciences
Colleen Clancy, PhD
Professor, Dept. Pharmacology
University of California, Davis
Robert Harrington, MD
Chair, Dept. of Medicine
Stanford University School of Medicine
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute
Stanford University School of Medicine
Philip Sager, MD
Chair
FDA Cardiorenal Drugs Advisory Committee
Mark Mercola, PhD
Professor
Stanford University
Charles Holmsey, MD
Venture Partner, Third Rock Ventures
Chaitan Khosla, PhD
Director
Stanford ChEM-H
Russ Altman, MD, PhD
Professor, Bioengineering and Genetics
Stanford University School of Medicine
Brian Kobilka, MD
Professor, Molecular & Cellular Physiology
Stanford University School of Medicine
Aarif Khakoo, MD
Executive Director Research and Site Head
Amgen South San Francisco
Bradley P. Morgan, Ph.D.
Vice President
Drug Discovery & Early Development
Cytokinetics, Inc.
Norman Stockbridge, MD, PhD
Director
Division of Cardiovascular and Renal Products, FDA
Jennifer Grandis, MD
Associate Vice Chancellor, Clinical and Translational Research
Director, Clinical and Translational Science Institute
UCSF School of Medicine